… that may not need treatment." The American Urological … more clinically significant cases of prostate cancer, 49% versus 29%, while … biopsy, said Kim.  The FDA has approved blood and … and genes associated with prostate cancer. Their results can help …

According to doctors, prostate cancer is a serious disease, and it is common. For every 100 men, experts believe at least 13 will develop prostate cancer at some point in their lives. Fortunately, most people get diagnosed before it spreads beyond their …

… as half of new FDA-approved drugs contain fluorine. However, … derivatives of flutamide (a prostate cancer drug) and fentanyl (an opioid … attaching radioactive tracers to drug molecules at the … it will accelerate both drug discovery and diagnostic imaging,” …

… major breakthrough in both cancer treatment innovation and the UK’ … cancers that traditional treatments often struggle to treat, including prostate cancer and neuroendocrine cancers … nuclear material into precision cancer treatments, we’re opening new …

… expand collaborations with global pharma. The new site is … drug-delivery platform that aims to turn short half-life peptide drugs … of its once-monthly prostate cancer therapy Leupone (leuprorelin acetate … a Parkinson’s disease treatment. Peptron added that the …

… prostate cancer treatment with a fresh FDA … androgen-directed prostate cancer med Zytiga (abiraterone … medication prednisone to delay disease progression of the aggressive form of prostate cancer … drug class to extend beyond a niche subgroup of prostate cancer …

… Food and Drug Administration (FDA). At the time, the FDA said it … success with its flagship prostate cancer imaging product, Illuccix. Once … progresses well, Telix Pharmaceuticals could well have a long … also positive on Telix Pharmaceutical shares. It has a …

… trial readout in the March quarter and hopes to have the treatment … US Food and Drug Administration (FDA). This qualifies the … initiated research on Telix Pharmaceuticals (ASX:TLX) with … commercialised imaging agents for prostate cancer (Iluccix and Gozellix). …

… of treatments are offered for prostate cancer? “Some men who are diagnosed with prostate cancer … have a type of cancer that’s so slow-growing, treatment … or to have radiotherapy to treat that whole prostate area and …

… therapies are experimental treatments for localised prostate cancer. Focal therapies destroy … The aim is to treat the cancer with less … But what happens if prostate cancer comes back after focal … focal therapy make subsequent treatment more difficult? Source …